Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf food noise has returned while you're on Mounjaro, you're not imagining it. The mental chatter around eating can resurface during a dose titration, after a missed injection, or when appetite-suppressing effects settle at a particular strength. Mounjaro (tirzepatide) works partly by dampening the brain's preoccupation with food, but that effect isn't fixed — it fluctuates with dose and timing. This is a prescription-only medicine, so any changes to how you're responding should be discussed with your prescriber, who can review whether your current dose is still right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before assuming Mounjaro has stopped working, it helps to trace back what shifted. The three most common triggers our prescribers hear about are a late or missed injection, a recent dose increase that hasn't yet reached its steadiest effect, and a period of stress or disrupted sleep, both of which independently raise appetite-driving hormones regardless of medication.
Tirzepatide is a dual GIP and GLP-1 receptor agonist; it reduces food noise partly by slowing gastric emptying and partly through central appetite pathways in the brain. When a dose is overdue by even a day or two, plasma levels of the medicine drop enough for those pathways to become noisier again. If you've recently had to pause treatment and restart, you may have been stepped back down the dose ladder, which means the effect you'd adapted to is temporarily gone. The mechanism behind how Mounjaro quiets food noise is worth understanding in full if this is new to you, because it sets realistic expectations for how quickly any change beds in.
Keep a rough log for a week: when did food noise spike, and what had changed beforehand? That record is genuinely useful to bring to your next clinical review. A prescriber can see at a glance whether timing, dose, or something else is the more likely culprit.
Tirzepatide reduces appetite, it doesn't replace the need for thoughtful eating choices. High-glycaemic meals cause a sharper blood-sugar rise and fall, which can trigger hunger signals even when the medicine is active. Very low calorie days, or days where protein intake is minimal, often amplify cravings rather than suppress them because the body ramps up hunger hormones to compensate.
Protein is worth prioritising at each meal. It takes longer to digest, keeps you fuller for longer, and preserves muscle mass during weight loss, a particular concern when appetite is suppressed and overall intake falls. Adequate hydration matters too; thirst is frequently misread as hunger, and this is more pronounced when nausea or GI symptoms have reduced your usual fluid intake.
Our guide to what to eat on Mounjaro covers the practical detail, including meal structure and the foods that tend to sit better during titration. There's also a companion page on foods that commonly worsen GI side effects if that's part of the picture.
Getting this right isn't about restriction, it's about working with the medicine rather than accidentally working against it. A registered dietitian can build a personalised plan if general advice isn't moving the needle.
Food noise coming back is clinical information. It tells your prescriber something real about how treatment is currently working for you, and that conversation shouldn't wait until your next scheduled review if the change is significant.
Dose optimisation is one of the levers available. NICE's appraisal of tirzepatide (TA1026) notes that treatment response is reviewed on an ongoing basis, and that continuing at a dose where response is insufficient needs to be considered carefully. Your prescriber can weigh whether moving to a higher dose is appropriate, whether timing of your injection needs reviewing, or whether something in your circumstances has changed that calls for a different approach.
The full overview of Mounjaro explains the dose schedule in context if you want to understand where you sit in the titration pathway. And if you've been reading about tirzepatide more broadly, the conditions tirzepatide is licensed to treat page clarifies the full picture of how this medicine is used in the UK.
At nume, every repeat order is clinically reviewed before it's approved, a real prescriber reads your notes each time, not an automated system. If food noise returning is a pattern, raising it through our aftercare team means it reaches your prescriber directly. That's the point of having clinical oversight rather than a subscription that ships automatically.
For context on the costs involved in private treatment, our Mounjaro price comparison page sets out what's included in a legitimate private prescription and what questions to ask any provider.
If you're not yet on treatment and food noise is part of why you're considering Mounjaro, the NHS's patient information on tirzepatide is a solid starting point, and NICE's guidance (TA1026) explains who the medicine is recommended for in the UK.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.